Savara is a Texas-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of respiratory diseases.
Business Model:
Revenue: $257k
Employees: 11-50
Savara was acquired by
Mast Therapeutics.
The acquisition happend on 2017-01-09.
Details of the transaction were not public
Address: 6836 Bee Cave Road
City: Austin
State: TX
Zip: 78746
Country: US
Savara is a Texas-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of respiratory diseases.
Contact Phone:
+15126141848
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
6/1/2017
IPO Valuation:
$111M
Ticker Symbol:
SVRA
IPO Price:
$4.75/share
Amount Raised:
$40M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|---|---|
6/2016 | Serendex Pharmaceuticals |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|